BioPharma Credit PLC (BOPCF)

Market Cap	1.09B +11.8%
Revenue (ttm)	157.75M +5.1%
Net Income	129.89M +6.3%
EPS	0.11 +14.0%
Shares Out	n/a
PE Ratio	8.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	556
Open	0.9903
Previous Close	0.9693
Day's Range	0.9903 - 0.9903
52-Week Range	0.8503 - 1.0200
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 23, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

• Industry: Asset Management
• Sector: Financials
• Founded: 2016
• Country: United Kingdom
• Stock Exchange: OTCMKTS
• Ticker Symbol: BOPCF

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 11, 2026

Data Sources Report a data error